Positron Emission Tomography News and Research

RSS

Study finds PTSD as risk factor for heart disease among Vietnam vets

Male twin Vietnam veterans with post-traumatic stress disorder were more than twice as likely as those without PTSD to develop heart disease during a 13-year period, according to a study supported by the National Institutes of Health.

26 Jun 2013

Radionuclide drug treatment planning goes to next level with 3-D patient models

External beam radiation treatment has long been manipulated into the unique shape of patients' tumors for personalized cancer care. Technology providing a means of patient-specific radionuclide drug therapies has not been standardized, as it has been limited to software that requires oncologists to manually define the areas of tumors.

13 Jun 2013

Researcher improves segmentation technique of PET images

Elena Prieto-Azkarate, a graduate in Telecommunications Engineering at the NUP/UPNA-Public University of Navarre and member of the Nuclear Medicine Service of the University College Hospital of Navarre, has implemented 12 algorithms to process medical images produced by means of PET (Positron Emission Tomography).

13 Jun 2013

3D motion-tracked PET imaging uses MR micro-coils to reduce movement-related imaging artifacts

One of the biggest hurdles of hybrid positron emission tomography and magnetic resonance imaging is the prevalence of motion artifacts-blurring and ghostly visual anomalies caused by patient motion on the table during imaging.

13 Jun 2013

PET technique detects coronary disease much earlier than other leading imaging methods

Coronary artery disease (CAD) is one of the world's most prevalent and silent killers. Positron emission tomography (PET), which images miniscule abnormalities in cellular metabolism, can tip off clinicians about cardiac disasters waiting to happen- including sudden death from a heart attack-better than standard angiography, researchers revealed at the Society of Nuclear Medicine and Molecular Imaging's 2013 Annual Meeting.

12 Jun 2013

Hypometabolism in brain regions of cognitively normal patients associated with Alzheimer's disease

Alzheimer's disease has been linked in many studies to amyloid plaque buildup in the brain, but new research is finding a common thread between amyloid burden and lower energy levels, or metabolism, of neurons in certain areas of the brain associated with Alzheimer's disease-even for people with no sign of cognitive decline.

12 Jun 2013

New imaging system combines PET and MR for mapping recurrent prostate cancer

When prostate cancer makes a comeback, it becomes increasingly important to have exceptional imaging available to find all possible regions where cancer has spread to other parts of the body, or metastasized, in order to plan the best possible treatment.

12 Jun 2013

New SPECT and MR imaging systems unveiled at SNMMI's 2013 Annual Meeting

The Society of Nuclear Medicine and Molecular Imaging's 2013 Annual Meetingmarks the unveiling of the successful application of a new preclinical hybrid molecular imaging system-single photon emission tomography and magnetic resonance -which has exceptional molecular imaging capabilities in terms of potential preclinical and clinical applications, technological advancement at a lower cost, and reduction of patient exposure to ionizing radiation.

12 Jun 2013

Anti-nicotine vaccination can increase accumulation of nicotine in the brain, say neuroscientists

Researchers have yet again been sent back to the drawing board in the development of the much-sought-after vaccination for smokers, which would hypothetically inhibit the action of nicotine and its pleasure-producing chemical response in the brain.

12 Jun 2013

PET and MR imaging can improve quality of life and survival for advanced breast cancer patients

For patients with advanced breast cancer, positron emission tomography and magnetic resonance imaging can improve quality of life and survival by providing physicians with information on the effectiveness of chemotherapy prior to surgery, say researchers presenting at the 2013 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging.

12 Jun 2013

New weapon in the fight against childhood brain cancer emerges

A relatively new weapon in the fight against childhood brain cancer has emerged that improves upon standard magnetic resonance imaging by providing information about tumor metabolism and extent of cancer in children diagnosed with glioma, a growth caused by the abnormal division of glial cells in the brain, say researchers at the Society of Nuclear Medicine and Molecular Imaging's 2013 Annual Meeting.

11 Jun 2013

Johns Hopkins expert in brain imaging receives 2013 Paul C. Aebersold Award

A Johns Hopkins expert in brain imaging, Dean F. Wong, M.D., Ph.D., has been honored with the prestigious 2013 Paul C. Aebersold Award for his contributions over the past 30 years in applying basic science to the field of nuclear medicine.

11 Jun 2013

Sugar ingestion associated with low dopamine release in patients with insulin resistance

Using positron emission tomography (PET) imaging of the brain, researchers have identified a sweet spot that operates in a disorderly way when simple sugars are introduced to people with insulin resistance, a precursor to type 2 diabetes.

11 Jun 2013

New research proves value of PET/MR compared to PET/CT in cardiac applications

Just a few years ago, integrated positron emission tomography and magnetic resonance (PET/MR) imaging was found only in research institutes, but little by little the technology has expanded into clinical practice.

11 Jun 2013

Concert Pharmaceuticals announces initiation of CTP-354 Phase 1 trial in healthy volunteers

Concert Pharmaceuticals, Inc. today announced that it has initiated a Phase 1 clinical trial with CTP-354. CTP-354 is a novel GABAA receptor subtype-selective modulator that has demonstrated no sedation at therapeutic doses in preclinical models in contrast to existing GABAA receptor non-selective agonists, such as benzodiazepines.

10 Jun 2013

Study: Neural reserve, neural compensation activated in highly educated prodromal Alzheimer's patients

Highly educated individuals with mild cognitive impairment that later progressed to Alzheimer's disease cope better with the disease than individuals with a lower level of education in the same situation, according to research published in the June issue of The Journal of Nuclear Medicine.

4 Jun 2013

Omeros announces positive results from OMS824 Phase 1 clinical program

Omeros Corporation today announced positive results from its Phase 1 clinical program evaluating OMS824, the lead compound from its phosphodiesterase 10 (PDE10) program.

31 May 2013

Zecotek welcomes Markman hearing for infringement of LFS scintillation crystal patent

Zecotek Photonics Inc., a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that the claim construction hearing, also called a Markman hearing, for Zecotek Imaging Systems Pte Ltd.'s legal action against defendants Saint-Gobain Corporation and Philips will be held on July 2, 2013, before U.S. District Judge Sara Lioi .

28 May 2013

Cognoptix' SAPPHIRE II eye test identifies Alzheimer's disease patients via Ab signature in the eyes

Cognoptix, an emerging medical device company, announced today that its SAPPHIRE II eye test identified Alzheimer's disease patients via a beta amyloid ("Ab") signature in their eyes in a 10-subject proof-of-concept clinical trial.

23 May 2013

Noninvasive imaging tests may play bigger role in diabetes management

New approaches to applying noninvasive imaging tests such as computed tomography, magnetic resonance, and positron emission tomography may play a bigger role in evaluating and managing patients with diabetes.

14 May 2013

Positron Emission Tomography News and Research

Study finds PTSD as risk factor for heart disease among Vietnam vets

Radionuclide drug treatment planning goes to next level with 3-D patient models

Researcher improves segmentation technique of PET images

3D motion-tracked PET imaging uses MR micro-coils to reduce movement-related imaging artifacts

PET technique detects coronary disease much earlier than other leading imaging methods

Hypometabolism in brain regions of cognitively normal patients associated with Alzheimer's disease

New imaging system combines PET and MR for mapping recurrent prostate cancer

New SPECT and MR imaging systems unveiled at SNMMI's 2013 Annual Meeting

Anti-nicotine vaccination can increase accumulation of nicotine in the brain, say neuroscientists

PET and MR imaging can improve quality of life and survival for advanced breast cancer patients

New weapon in the fight against childhood brain cancer emerges

Johns Hopkins expert in brain imaging receives 2013 Paul C. Aebersold Award

Sugar ingestion associated with low dopamine release in patients with insulin resistance

New research proves value of PET/MR compared to PET/CT in cardiac applications

Concert Pharmaceuticals announces initiation of CTP-354 Phase 1 trial in healthy volunteers

Study: Neural reserve, neural compensation activated in highly educated prodromal Alzheimer's patients

Omeros announces positive results from OMS824 Phase 1 clinical program

Zecotek welcomes Markman hearing for infringement of LFS scintillation crystal patent

Cognoptix' SAPPHIRE II eye test identifies Alzheimer's disease patients via Ab signature in the eyes

Noninvasive imaging tests may play bigger role in diabetes management

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News